[11C]Cimbi-36 launced at Imanova in London as new imaging biomarker to investigate the serotonin system in psychiatric illness

Main Menu

Login Form

Feb 23rd, Imanova, Centre for Imaging Sciences, London announced completion of the implementation of [11C]Cimbi-36 as a novel imaging biomarker for use in clinical and preclinical PET imaging studies.

For more details, please read the official press release.

Latest Publications

Pretargeted imaging beyond the blood-brain barrier
Hippocampal volume changes in a pharmacological sex-hormone manipulation risk model for depression in women
Correction: Glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with differences in uncinated fasciculus microstructure
Brain structure associations with phonemic and semantic fluency in typically-developing children
Glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with differences in uncinate fasciculus microstructure

Main Menu

Login Form

News archive

[11C]Cimbi-36 launced at Imanova in London as new imaging biomarker to investigate the serotonin system in psychiatric illness

Latest Publications